ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,692Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 783

$906K Total Retail Price of All Prescriptions

Rank: 65 out of 783

348 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 348 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

31% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 11,440 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 784 475 S3 1 2
AMLODIPINE BESYLATE 540 480 2 5
OMEPRAZOLE 537 366 3 6
SIMVASTATIN 522 351 4 3
ATORVASTATIN CALCIUM 416 311 5 11
FUROSEMIDE 395 315 6 7
METOPROLOL SUCCINATE 325 281 7 13
SYNTHROID 316 247 8 47
GABAPENTIN 309 230 9 15
CRESTOR 297 209 10 27
ISOSORBIDE MONONITRATE ER 281 211 11 40
POTASSIUM CHLORIDE 279 211 12 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 265 158 13 33
WARFARIN SODIUM 247 232 14 10
LISINOPRIL 220 162 15 4
ZOLPIDEM TARTRATE 212 150 16 23
LEVOTHYROXINE SODIUM 201 162 17 1
METFORMIN HCL 192 102 18 8
METOPROLOL TARTRATE 192 129 18 9
TRAMADOL HCL 187 150 20 20
ESCITALOPRAM OXALATE 185 128 21 54
POLYETHYLENE GLYCOL 3350 174 133 22 43
CITALOPRAM HBR 172 129 23 19
CIPROFLOXACIN HCL 167 136 24 62
LANTUS 166 122 25 38
GLIMEPIRIDE 157 105 26 34
NEXIUM 155 126 27 28
CLOPIDOGREL 149 127 28 29
NAMENDA 144 144 29 32
FENTANYL 129 82 S2 30 65
MELOXICAM 128 92 31 37
SERTRALINE HCL 123 100 32 22
SEROQUEL XR 116 58 33 314
PROAIR HFA 107 62 34 56
PLAVIX 104 93 35 51
CARVEDILOL 104 77 35 21
SYMBICORT 99 52 37 157
DONEPEZIL HCL 99 99 37 24
MIRTAZAPINE 96 86 39 52
HYDROCHLOROTHIAZIDE 95 84 40 12
DIOVAN HCT 92 68 41 94
HYDRALAZINE HCL 88 83 42 78
PROMETHAZINE HCL 87 45 R 43 97
LEVOFLOXACIN 82 57 44 75
INSULIN SYRINGE 82 33 44 82
SPIRONOLACTONE 82 35 44 57
METHYLPREDNISOLONE 80 47 47 138
BENAZEPRIL HCL 78 56 48 85
NOVOLOG 78 67 48 81
TIZANIDINE HCL 78 23 48 133
CYMBALTA 76 49 51 35
CYCLOBENZAPRINE HCL 76 18 R 51 63
BYSTOLIC 72 36 53 99
ALLOPURINOL 70 29 54 31
LIPITOR 69 46 55 114
TRIAMTERENE-HCTZ 68 47 56 42
DIGOXIN 68 68 56 61
PREDNISONE 67 52 58 36
PHENYTOIN SODIUM EXTENDED 67 63 58 141
BUMETANIDE 65 39 60 131
GLIPIZIDE 64 54 61 71
CLONIDINE HCL 64 35 61 60
TOPIRAMATE 64 23 61 152
VENLAFAXINE HCL ER 63 15 64 100
JANUVIA 62 55 65 73
DILTIAZEM 24HR CD 61 48 66 118
CARBIDOPA-LEVODOPA 61 61 66 88
TAMSULOSIN HCL 61 51 66 26
HUMALOG 60 50 69 101
FLUCONAZOLE 59 37 70 179
SPIRIVA 59 48 70 59
FAMOTIDINE 58 58 72 55
FENOFIBRATE 57 42 73 66
PANTOPRAZOLE SODIUM 56 35 74 30
LIDODERM 56 50 74 132
LEXAPRO 56 40 74 181
ATENOLOL 55 51 77 17
DIOVAN 54 42 78 49
FLUOXETINE HCL 54 38 78 45
QUETIAPINE FUMARATE 52 28 80 79
OXYCODONE HCL-ACETAMINOPHEN 52 23 S2 80 86
CLOTRIMAZOLE-BETAMETHASONE 51 35 82 189
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.